UNSPSC 51473302: Chloroxylenol

This classification denotes an anti-infective agent with the molecular formula C8H9ClO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0F32U78V2Q, chemically known as 3,5-xylenol, 4-chloro- but generally known as chloroxylenol, which bears US NIH Compound Identifier 2723. European Medicines Agency schedules Chloroxylenol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06200MIG.

UNSPSC 51473302 Chloroxylenol, a Commodity code, encompasses antimicrobial cleaning and disinfecting agents that state and local governments procure for facility maintenance and public health operations. The recent solicitations show this code capturing demand for consumable janitorial supplies in high-volume environments and for over-the-counter pharmaceutical and antiseptic products distributed across multi-state cooperative purchasing networks. Issuing bodies include county governments and state-administered cooperative purchasing alliances that consolidate demand across participating jurisdictions. The scope spans routine facility sanitation supplies for fire departments and emergency services as well as OTC antimicrobial products for healthcare and institutional distribution through licensed pharmaceutical wholesalers.

Activity concentrates in Florida and Minnesota, with the latter representing multi-state reach through the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP). Hillsborough County Board of County Commissioners issued an IFB (ITB2600319) on July 7, 2026, due July 24, 2026, for janitorial and operational supplies supporting 47 fire stations with an estimated contract value of $765,679.84 for one year; delivery to the Public Safety Operations Complex in Tampa, Florida. The Minnesota Department of Administration's Office of State Procurement, administering MMCAP, issued an RFP (S1070000015802) on January 20, 2026, due March 26, 2026, to establish multiple contracts for generic multi-source pharmaceuticals and OTC products across participating state and local facilities, with awarded vendors effective July 1, 2026. Both solicitations require authorized distributor status, cGMP or equivalent certification, compliance with pharmaceutical supply-chain regulations, and FOB-destination or wholesaler-based fulfillment models.